Arvinas-Pfizer Partner Cancer Drug Trial Shows 63% Clinical Benefit In Breast Cancer Patients
Arvinas, Inc · PHARMACEUTICAL PREPARATIONS · Now $8.58
+6.4% in 1d after detection
Post-detection moves
1h
—
1d
+6.4%
3d
+6.3%
7d
+5.0%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS